113 related articles for article (PubMed ID: 21845306)
1. [Atorvastatin induced increase in homologous angiotensin I converting enzyme (ACE2) mRNA is associated to decreased fibrosis and decreased left ventricular hypertrophy in a rat model of diabetic cardiomyopathy].
Aguilar C; Ventura F; Rodríguez-Delfín L
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):264-72. PubMed ID: 21845306
[TBL] [Abstract][Full Text] [Related]
2. [Effect of atorvastatin on ACE2 expression in pressure overload induced cardiac hypertrophy in rats].
Qin XT; Jia CW; Pan M; Shen AG; Jing HM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):438-42. PubMed ID: 18544849
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.
Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y
J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.
Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C
J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats.
Cheng G; Xu G; Cai HW; Wang HH; Bao XF
Acta Pharmacol Sin; 2007 Apr; 28(4):511-7. PubMed ID: 17376290
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Senthil V; Chen SN; Tsybouleva N; Halder T; Nagueh SF; Willerson JT; Roberts R; Marian AJ
Circ Res; 2005 Aug; 97(3):285-92. PubMed ID: 16020756
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.
Van Linthout S; Riad A; Dhayat N; Spillmann F; Du J; Dhayat S; Westermann D; Hilfiker-Kleiner D; Noutsias M; Laufs U; Schultheiss HP; Tschöpe C
Diabetologia; 2007 Sep; 50(9):1977-1986. PubMed ID: 17589825
[TBL] [Abstract][Full Text] [Related]
10. Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications.
Tikoo K; Patel G; Kumar S; Karpe PA; Sanghavi M; Malek V; Srinivasan K
Biochem Pharmacol; 2015 Feb; 93(3):343-51. PubMed ID: 25482567
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.
Li WM; Liu W; Gao C; Zhou BG
Immunol Cell Biol; 2006 Jun; 84(3):274-80. PubMed ID: 16509827
[TBL] [Abstract][Full Text] [Related]
12. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.
Burchill L; Velkoska E; Dean RG; Lew RA; Smith AI; Levidiotis V; Burrell LM
Exp Physiol; 2008 May; 93(5):622-30. PubMed ID: 18223026
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response.
Song XJ; Yang CY; Liu B; Wei Q; Korkor MT; Liu JY; Yang P
Int J Med Sci; 2011; 8(7):564-72. PubMed ID: 21960749
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
[TBL] [Abstract][Full Text] [Related]
16. The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts.
Shin YH; Min JJ; Lee JH; Kim EH; Kim GE; Kim MH; Lee JJ; Ahn HJ
Heart Vessels; 2017 May; 32(5):618-627. PubMed ID: 28013371
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
18. Alteration of cardiac ACE2/Mas expression and cardiac remodelling in rats with aortic constriction.
Zhang Y; Li B; Wang B; Zhang J; Wu J; Morgan T
Chin J Physiol; 2014 Dec; 57(6):335-42. PubMed ID: 25575522
[TBL] [Abstract][Full Text] [Related]
19. Myocardial infarction increases ACE2 expression in rat and humans.
Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
